#155100

Anti-FVIII [MBC 103.3]

Cat. #155100

Anti-FVIII [MBC 103.3]

Cat. #: 155100

Unit size: 100 ug

Availability: 10-12 weeks

Target: Factor VIII

Class: Monoclonal

Application: ELISA ; IF

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Versiti Blood Research Institute

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-FVIII [MBC 103.3]
  • Alternate name: FVIII
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 250
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; IF
  • Description: Factor VIII is an essential blood-clotting protein encoded by the F8 gene in humans. This protein circulates in the blood stream in an inactive form, bound to vWF, until an injury that damages blood vessels occurs.
  • Immunogen: FVIII
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: IgG1

Target Details

  • Target: Factor VIII
  • Molecular weight: 250
  • Target background: Factor VIII is an essential blood-clotting protein encoded by the F8 gene in humans. This protein circulates in the blood stream in an inactive form, bound to vWF, until an injury that damages blood vessels occurs.

Applications

  • Application: ELISA ; IF

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Yarovoi et al. 2005. Blood. 105(12):4674-6. PMID: 15731176.
  • Wilcox et al. 2003. J Thromb Haemost. 1(12):2477-89. PMID: 14675082.
  • Rosenberg et al. 2000. Arterioscler Thromb Vasc Biol. 20(12):2689-95. PMID: 11116073.
  • Rosenberg et al. 1998. J Clin Invest. 101(3):613-24. PMID: 9449695.